Buzzing stocks: GRSE, Dr Reddy’s, Lupin, NBCC, HPCL, Belrise and Datakosa in focus
From GRSE’s ₹32,000-crore Indian Navy contract and USFDA approvals for pharma companies to fresh infrastructure, AI automation and laptop supply orders, several companies announced significant business developments
Indian shipbuilder GRSE signed a contract worth ₹32,000 crore with the Indian Navy to construct five Next Generation Corvettes, advancing its role in the country's indigenous warship-building program. Meanwhile, pharmaceutical giant Dr Reddy's Laboratories secured USFDA approval for its HIV prevention drug lenacapavir, making it accessible in 120 countries under a licensing agreement.
Lupin Limited also received FDA approval for its Amifampridine Tablets, 10 mg. NBCC secured new work orders worth ₹70.50 crore from Oil India Ltd and HAL, bolstering its housing and defense-linked infrastructure projects. Hindustan Petroleum Corporation controlled a fire at its Visakhapatnam refinery without any damage to units.
Automotive component manufacturer Belrise Industries signed a license and technical assistance agreement with Japanese firm Yamato to manufacture and sell filtration and air intake products in India. Datakosa Ltd, formerly Bodhtree Consulting Ltd, received a $2.46-million order for AI-led automation, integration, and implementation services from US firm Hermes Networks Inc. Panache DigiLife secured a ₹51.43-crore laptop supply order from a domestic IT customer, to be executed within 30 days.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
